Castle biosciences announces preliminary fourth quarter and full-year 2022 results

Friendswood, texas--( business wire )--castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary performance results for the fourth quarter and full-year ended dec. 31, 2022.
CSTL Ratings Summary
CSTL Quant Ranking